Recently discovered CD8 + CXCR6 + PD-1+ T cells capable of auto-aggressive hepatocyte killing were found to initiate NASH and facilitate the transition to liver cancer [87]. Here, CXCR6 is linked to metabolic dysfunction-associated steatohepatitis.